Recruiting Cystic Fibrosis Studies in Philadelphia
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Diabetes is a major co-morbidity in pancreatic insufficient cystic fibrosis (PI-CF) and associated with worse outcomes. While reduced β-cell mass contributes to the insulin secretory defects that char...
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
This is a Phase 1/2 multicenter, open-label, single dose trial of SP-101 investigational gene therapy in adults with CF who are ineligible for or intolerant to CFTR modulator therapy....
About Cystic Fibrosis Clinical Trials in Philadelphia
Cystic fibrosis is a genetic disorder that causes thick, sticky mucus to build up in the lungs, digestive tract, and other organs. It is caused by mutations in the CFTR gene. CFTR modulator therapies have dramatically improved outcomes, along with airway clearance techniques and nutritional support.
There are currently 2 cystic fibrosis clinical trials recruiting participants in Philadelphia, PENNSYLVANIA. These studies are seeking a combined 45 participants. Research is being sponsored by University of Pennsylvania, Spirovant Sciences, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Cystic Fibrosis Clinical Trials in Philadelphia — FAQ
Are there cystic fibrosis clinical trials in Philadelphia?
Yes, there are 2 cystic fibrosis clinical trials currently recruiting in Philadelphia, PENNSYLVANIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What cystic fibrosis treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for cystic fibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov